Annual sales went from KRW 59.6 billion in 2022 to KRW 56.5 billion in 2023 (down 5.3% year on year), then rose to KRW 68.7 billion in 2024 (up 21.8%), the largest year in 2022–2025, before falling to KRW 56.8 billion in 2025 (down 17.4%).
Operating profit was largest in 2022 at KRW 8.52 billion, fell to KRW 3.56 billion in 2023 (down 58.2%), rose to KRW 6.54 billion in 2024 (up 83.7%) and was smallest in 2025 at KRW 1.03 billion (down 84.3%).
Operating margin moved from 14.3% to 6.3%, 9.5% and 1.8% over the same years, so profitability peaked in 2022 even though sales peaked in 2024.
Profit attributable to controlling shareholders followed a similar path: KRW 12.2 billion in 2022, KRW 3.73 billion in 2023, KRW 6.08 billion in 2024 and KRW 935 million in 2025. Net income including non-controlling interests was KRW 947 million in 2025.
A December 2023 analysis attributed the 2023 decline to customers cutting production and falling utilization at global OSATs, which reduced back-end equipment orders.
On a quarterly basis, Genesem swung from an operating loss of KRW 372 million in the third quarter of 2025 to operating profit of KRW 54.18 million in the fourth quarter, then to an operating loss of KRW 2.47 billion in the first quarter of 2026, which was the low point.
Operating profit then recovered to KRW 4.17 billion in the second quarter and KRW 2.57 billion in the third quarter of 2026, although third-quarter operating profit fell 38.5% from the prior quarter.
The company said rising raw material and labor costs and higher costs from expanding production capacity partly weighed on profitability. Profit attributable to controlling shareholders over the last four quarters totals KRW 1.19 billion, which remains small relative to the sales recovery.